Combination vitamin D therapy in stage 5 chronic kidney disease;Terapia de combinación de vitamina D en enfermedad crónica del riñón en estadío 5

Annals of Pharmacotherapy

Volumn 45, Issue 7-8, 2011, Pages 1011-1015

  Vondracek, Sheryl F ^a   Hoody, Dorie W ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cholecalciferol; Chronic kidney disease; Ergocalciferol; Hemodialysis; Vitamin D; Vitamin D receptor activators

Indexed keywords

25 HYDROXYVITAMIN D; ALFACALCIDOL; CALCIFEDIOL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; PARATHYROID HORMONE; PARICALCITOL;

ARTICLE; BONE METABOLISM; BONE MINERAL; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COMBINATION CHEMOTHERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; EMBASE; HEMODIALYSIS PATIENT; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; MEDLINE; OBSERVATIONAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SECONDARY HYPERPARATHYROIDISM; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; BONE RESORPTION; CHOLECALCIFEROL; DRUG THERAPY, COMBINATION; ERGOCALCIFEROLS; HUMANS; KIDNEY FAILURE, CHRONIC; RECEPTORS, CALCITRIOL; SEVERITY OF ILLNESS INDEX; VITAMIN D;

EID: 79960801727     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P782     Document Type: Article

References (22)

1. Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 2004;24:503-10. DOI 10.1159/000081023.
2. Tolouian R, Rao DS, Goggins M, Bhat S, Gupta A. Seasonal variation of vitamin D in patients on hemodialysis. Clin Nephrol 2010;74:19-24.
3. Bednarek-Skublewska A, Smolen A, Jaroszynski A, Zaluska W, Ksiazek A. Effects of vitamin D3 on selected biochemical parameters of nutritional status, inflammation, and cardiovascular disease in patients undergoing long-term hemodialysis. Pol Arch Med 2010;120:167-74.
4. Jones G. Why dialysis patients need combination therapy with both cholecalciferol and a calcitriol analogs. Semin Dial 2010;23:239-43. DOI 10.1111/j.1525-139X.2010.00722.x
5. Wesseling-Perry K, Salusky IB. Is replacement therapy with nutritional and active forms of vitamin D required in chronic kidney disease mineral and bone disorder? Curr Opin Nephrol Hypertens 2009;18:308-14. DOI 10.1097/MNH.0b013e32832c7654
6. Williams S, Malatesta K, Norris K. Vitamin D and chronic kidney disease. Ethn Dis 2009;19(suppl 5):S8-S11.
7. Cronin SC. The dual vitamin D pathways: considerations for adequate supplementation. Nephrol Nurs J 2010;37:19-26.
8. Drechsler C, Verduijn M, Pilz S, et al. Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant 2011;26:1024-32. DOI 10.1093/ndt/gfq606
9. Binkley N, Ramamurthy R, Krueger D. Low vitamin D status: definition, prevalence, consequences, and correction. Endocrinol Metab Clin North Am 2010;39:287-301. DOI 10.1016/j.ecl.2010.02.008
10. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD -MBD). Kidney Int Suppl 2009:S1-S130. DOI 10.1038/ki.2009.191
11. Drechsler C, Pilz S, Obermayer-Pietsch B, et al. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J 2010;31:2253-61. DOI 10.1093/eurheartj/ehq246
12. Jean G, Lataillade D, Genet L, et al. Impact of hypovitaminosis D and al-facalcidol therapy on survival of hemodialysis patients: results from the French ARNOS Study. Nephron Clin Pract 2011;118:204-10. DOI 10.1159/000321507
13. Wang AY, Lam CW, Sanderson JE, et al. Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am J Clin Nutr 2008;87:1631-8.
14. Pecovnik-Balon B, Jakopin E, Bevc S, Knehtl M, Gorenjak M. Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients. Ther Apher Dial 2009;13:268-72. DOI 0.1111/j.1744-9987.2009.00722.x
15. Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007;72:1004-13. DOI 10.1038/sj.ki.5002451
16. Tokmak F, Quack I, Schieren G, et al. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant 2008;23:4016-20. DOI 10.1093/ndt/gfn367
17. Jean G, Terrat JC, Vanel T, et al. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant 2008;23:3670-6. DOI 10.1093/ndt/gfn339
18. Jean G, Vanel T, Terrat JC, Chazot C. Prevention of secondary hyper-parathyroidism in hemodialysis patients: the key role of native vitamin D supplementation. Hemodial Int 2010;14:486-91. DOI 10.1111/j.1542- 4758.2010.00472.x
19. Matias PJ, Jorge C, Ferreira C, et al. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol 2010;5:905-11. DOI:10.2215/ CJN.06510909
20. Saab G, Young DO, Gincherman Y, Giles K, Norwood K, Coyne DW. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract 2007;105:132-8. DOI 10.1159/000098645
21. Ross CA, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;6:53-8. DOI 10.1210/jc.2010-2704
22. Kandula P, Dobre M, Schold JD, Schreiber MJ, Mehrotra R, Nava-neethan SD. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 2011;6:50-62. DOI 10.2215/CJN.03940510